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levated coexpression of colony-stimulating factor
receptor (CSF-1R) and its ligand, CSF-1, correlates with
invasiveness and poor prognosis of a variety of epithelial
tumors (Kacinski, B.M. 1995. 
 
Ann
 
. 
 
Med
 
. 27:79–85). Apart
from recruitment of macrophages to the tumor site, the
mechanisms by which CSF-1 may potentiate invasion are
poorly understood. We show that autocrine CSF-1R activation
induces hyperproliferation and a profound, progressive
disruption of junctional integrity in acinar structures formed
by human mammary epithelial cells in three-dimensional
culture. Acini coexpressing receptor and ligand exhibit a
E
 
dramatic relocalization of E-cadherin from the plasma
membrane to punctate intracellular vesicles, accompanied
by its loss from the Triton-insoluble fraction. Interfering with
Src kinase activity, either by pharmacological inhibition or
mutation of the Y561 docking site on CSF-1R, prevents
E-cadherin translocation, suggesting that CSF-1R disrupts
cell adhesion by uncoupling adherens junction complexes
from the cytoskeleton and promoting cadherin internalization
through a Src-dependent mechanism. These ﬁndings provide
a mechanistic basis whereby CSF-1R could contribute to
invasive progression in epithelial cancers.
 
Introduction
 
Glandular morphogenesis is directed by a convergence of
diverse extracellular signals, including secreted trophic factors,
interaction with the ECM, and contact with neighboring
cells (Alford and Taylor-Papadimitriou, 1996; Niemann et
al., 1998; Schmeichel et al., 1998). One essential class of
soluble factors acts as ligands for receptor tyrosine kinases
(RTKs), initiating signaling cascades that promote the
proliferation and differentiation of epithelial cells and or-
chestrate the assembly of polarized glandular structures.
Appropriate regulation of receptor activity is crucial for the
establishment and maintenance of normal epithelial archi-
tecture, and aberrant activation of such signals can promote
tumor progression.
Several RTKs, including c-Met and EGFR, have been
implicated in the growth and morphogenesis of the mammary
epithelium, an arborized ductal network composed of
hollow tubules that terminate in secretory acinar units
(Niemann et al., 1998). Unlike many quiescent adult tissues,
the mammary epithelium must retain a broad spectrum of
developmental capacities for the duration of the mammalian
reproductive lifetime, to facilitate rapid lobuloaveolar
outgrowth and lactogenic differentiation during pregnancy.
Colony-stimulating factor receptor (CSF-1R) is an RTK
required for outgrowth of the mammary ductal network and
lactation (Dai et al., 2002). In the absence of CSF-1R or its
ligand, CSF-1, expansion of the mammary epithelium into
the surrounding fatty stroma is restricted, a defect that has
been attributed to the loss of macrophage recruitment to the
developing gland (Pollard and Hennighausen, 1994; Van
Nguyen and Pollard, 2002). Elevated expression of CSF-1R
has been described for a variety of malignancies of epithelial
origin, including breast, prostate, and ovarian carcinomas,
but the mechanisms by which the receptor contributes to
tumor development and progression remain incompletely
understood (Kacinski, 1995; Ide et al., 2002). While invasive
tumors may rely on cooperation with inflammatory cells,
both in vivo and in vitro data support a multifaceted role for
CSF-1R in tumorigenesis. In addition to macrophages,
CSF-1R is expressed in the mammary epithelium of pregnant
and lactating women (Sapi et al., 1998a). Furthermore,
elevated epithelial coexpression of CSF-1R and CSF-1 has
been described for 
 
 
 
50% of mammary tumors, and correlates
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with invasiveness in both tumors and several mammary car-
cinoma cell lines (Kacinski et al., 1991).
These data imply that CSF-1 may also act in an autocrine
fashion to potentiate tumor cell invasion. In support of this,
introduction of CSF-1R in noninvasive HC11 murine
mammary epithelial cells, which express CSF-1, enhanced
invasion through a Matrigel™ barrier by 100-fold (Sapi et
al., 1996). In contrast, a complete inhibition of the invasive
activity of BT20 breast tumor cells, which express high levels
of both receptor and ligand, was achieved by expression of a
dominant-negative mutant of Ets-2, a transcription factor
that acts as a key mediator of the cellular response to CSF-1
(Langer et al., 1992; Sapi et al., 1998b). However, such
studies do not assess the impact of autocrine CSF-1R signal-
ing in the context of intact glandular structures, and little is
known about the critical downstream signals that may be in-
volved in potentiating invasive behavior.
While the essential role for CSF-1 in mammary develop-
ment was revealed through mouse knockout studies, detec-
tion of the receptor in the murine gland has thus far been re-
stricted to infiltrating macrophages. Interestingly, epithelial
expression of the CSF-1R transcript in human mammary
epithelium is hormonally regulated via a glucocorticoid re-
sponse element that is absent from the murine locus (Flick et
al., 2002). Thus, while mouse models have contributed
much to an understanding of the role that macrophages, re-
cruited to the mammary gland by CSF-1 secretion, can play
in tumor progression, other model systems may be needed
to reveal the mechanisms by which autocrine signaling can
contribute to invasion in human tumors. Therefore, we have
examined the consequences of CSF-1R signaling on epithe-
lial cell behavior in the nontransformed human mammary
cell line MCF-10A. To enable a careful dissection of specific
alterations in epithelial physiology induced by CSF-1R, we
have employed a three-dimensional (3D) basement mem-
brane culture system in which MCF-10A cells assemble into
spherical structures that recapitulate many features of lobu-
lar acini in vivo (Barcellos-Hoff et al., 1989). This system is
tractable to biochemical and cell biological analysis, and has
been used previously by our laboratory to analyze the biolog-
ical activities of various oncogenes (Muthuswamy et al.,
2001; Debnath et al., 2002).
Here we demonstrate that constitutive CSF-1R activation
results in a striking and progressive disruption of cell–cell
adhesion in MCF-10A acini. In cells expressing either a con-
stitutively active form of the receptor, or coexpressing wild-
type receptor and CSF-1 ligand, initial acinar development
proceeds normally. However, in either context of CSF-1R
hyperstimulation, structures fail to form lumen, become hy-
perproliferative, and progressively lose junctional stability
and basement membrane integrity, culminating in the re-
lease of individual cells into the surrounding matrix. While
chronic CSF-1R activation does not alter steady-state levels
or synthesis of the major epithelial cell adhesion molecule
E-cadherin, immunofluorescence studies indicate that E-cad-
herin is lost from the plasma membrane and adopts a punc-
tate localization. In addition, interaction of adherens junc-
tion complexes with the Triton-insoluble cytoskeleton is
disrupted, impeding the ability of MCF-10A cells to achieve
adhesive compaction. Interfering with the activity of Src
family kinases, either by pharmacological inhibition or by
mutation of the Y561 docking site on CSF-1R, suppresses
the adhesion phenotype. These results suggest that CSF-1R
activation, possibly by an autocrine mechanism, can pro-
foundly disrupt the junctional integrity and architecture of
mammary epithelial acini in vitro via activation of a Src-
dependent pathway. These consequences distinguish hyper-
stimulation of CSF-1R from other RTKs examined in this
model, and provide insight into the mechanisms whereby
CSF-1 and its receptor could potentiate invasive activity
in vivo.
 
Results
 
CSF-1R activation supports EGF-independent 
proliferation and acinar development
 
The proliferation and 3D morphogenesis of MCF-10A cells
is dependent on the inclusion of EGF in the growth me-
dium. We initially sought to determine whether activation
of CSF-1R could promote proliferation and acinar develop-
ment in the absence of EGF. Significant expression of CSF-
1R in the mammary gland is observed only during late preg-
nancy and lactation; MCF-10As were derived from the
mammary tissue of a nonpregnant female, and do not ex-
press sufficient levels of CSF-1R to elicit a mitogenic re-
sponse to CSF-1. Therefore, to achieve higher receptor lev-
els, we infected these cells with a retroviral vector encoding
wild-type CSF-1R. Receptor expression and CSF-1–depen-
dent activation were confirmed by immunoblotting (Fig. 1
A). Cells expressing wild-type CSF-1R cultured as monolay-
ers in the presence of physiological levels of CSF-1 (10 ng/
ml) proliferated at a similar rate as cells cultured in EGF and
maintained a cobblestone phenotype (Fig. 1 B). In addition,
treatment of these cells with CSF-1 promoted the formation
of acini indistinguishable from those induced by EGF in 3D
Matrigel™ culture (Fig. 1 C) (Debnath et al., 2002).
 
Constitutive activation of CSF-1R disrupts MCF-10A 
acinar architecture
 
Previous studies have shown that constitutively active CSF-
1R has potent transforming activity in fibroblasts (Roussel et
al., 1987). To investigate whether deregulated CSF-1R sig-
naling could similarly perturb the behavior of MCF-10As,
we expressed an active variant of the receptor bearing two
point mutations essential for the transforming capacity of
the viral oncogene (
 
v-fms
 
). The mutation L301S in the ex-
tracellular domain permits ligand-independent receptor acti-
vation, and Y969F relieves an autoinhibitory regulatory
mechanism that may involve down-regulation of the recep-
tor via recruitment of Cbl (Roussel et al., 1988; Wilhelmsen
et al., 2002). Monolayers of MCF-10As expressing active
CSF-1R proliferated in the absence of ligand, adopted a
more refractile appearance, and displayed reduced contact
inhibition (Fig. 1 B). In 3D culture, the cells initiated mor-
phogenesis in the absence of exogenous growth factors and
initially formed spherical clusters with well-defined borders.
However, as morphogenesis progressed, these structures ex-
hibited enhanced proliferation and significantly increased
size relative to wild-type controls (Fig. 1 D). Furthermore, 
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after 
 
 
 
8–9 d in culture, acini exhibited a progressive loss of
structural integrity. The structures maintained a high prolif-
erative rate, became visibly discohesive, and individual cells
dissociated from the acini (Fig. 1 B). This phenotype is dis-
tinct from that induced by activation of ErbB2, which pro-
motes the formation of filled, multiacinar structures but
does not impact the integrity of the outer cell layer (Muth-
uswamy et al., 2001).
 
Autocrine or chronic stimulation of CSF-1R mimics the 
effects of constitutive activity on acinar integrity
 
While the presence of activating CSF-1R mutations in epithe-
lial tumors has not been confirmed, coexpression of CSF-1R
and CSF-1 is frequently observed in the epithelium of invasive
mammary carcinomas (Kacinski et al., 1991). This suggests
that autocrine CSF-1R activation may be sufficient to pro-
mote tumor progression. To determine whether autocrine sig-
naling could disrupt acinar structure, we generated MCF-
10As coexpressing CSF-1 and wild-type CSF-1R. Ligand
expression was confirmed by ELISA (unpublished data). Mono-
layers of cells expressing both ligand and receptor exhibited a
similar phenotype to those expressing constitutively active re-
ceptor (unpublished data). Furthermore, in 3D culture, these
cells initiated morphogenesis normally, but were hyperprolif-
erative; as a result, acini expanded greatly in size and failed to
undergo growth arrest. Similar to those expressing active re-
ceptor, these acini also exhibited a progressive architectural
disruption after 8–9 d, such that the integrity of the luminal
cell layer was compromised and single cells were released into
the matrix (Fig. 2 A; Fig. S1, available at http://www.jcb.org/
cgi/content/full/jcb.200309102/DC1). These results indicate
that activation of CSF-1R in an autocrine fashion can have
profound effects on in vitro acinar morphogenesis.
The development of discohesive structures upon CSF-1R
hyperstimulation suggested that constitutive receptor signal-
ing might impact molecules involved in cell–cell adhesion.
Consequently, we analyzed the localization of the adherens
junction proteins during morphogenesis. Acini formed in re-
sponse to exogenous CSF-1 exhibited well-defined cell–cell
junctions, illustrated by membrane localization of E-cad-
herin, concentrated toward the basal pole of the lateral
membrane (Fig. 3 A). Furthermore, acini formed lumen and
displayed aspects of polarity, basally deposited the ECM
protein laminin 5, and underwent proliferative arrest over a
similar time course as with acini grown in the presence of
EGF (Fig. 3, A and B) (Debnath et al., 2002).
Although E-cadherin initially exhibited a similar mem-
brane localization in acini coexpressing CSF-1R and CSF-1,
subsequently, it became diffusely localized, and immuno-
Figure 1. Constitutive CSF-1R activation alters MCF-10As mono-
layer morphology and acinar morphogenesis. (A) MCF-10A cells 
expressing wild-type or active CSF-1R were lysed in RIPA buffer and 
probed for receptor levels. Receptor activation was detected with a 
phospho-specific antibody to the Y723 autophosphorylation site. 
Cells were starved overnight in assay media, and where noted were 
treated with 10 ng/ml CSF-1 for 5 min before lysis. (B) Phase-contrast 
images of MCF-10A cells expressing wild-type or active CSF-1R 
cultured to confluence in assay media with growth factors noted in 
parentheses. (C) MCF-10A cells expressing wild-type or active CSF-1R 
were cultured in Matrigel
TM, and assay media with growth factors 
was replaced every 4 d. Brightfield images of day 5 and day 15 acini 
are shown. (D) The average size of MCF-10A acini was determined by 
microscopic area measurements using MetaMorph software (n   30).
Figure 2. Autocrine or chronic activation can mimic the active 
CSF-1R phenotype. (A) MCF-10As expressing CSF-1R and CSF-1 
were cultured in Matrigel
TM in assay media. Brightfield images of 
day 5 and day 19 acini are shown. (B) 3D cultures of cells expressing 
CSF-1R were stimulated daily with 10 ng/ml CSF-1. Phase-contrast 
images of day 5 and day 13 acini are shown. 
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staining was diminished (Fig. 3 C). Loss of membrane stain-
ing correlated with the degree of architectural disruption.
Concomitant with the relocalization of junctional compo-
nents, we observed disruption of the integrity of the basal
basement membrane and disordered deposition of laminin 5
in these structures (Fig. 3 D). Furthermore, the expansion in
size of the autocrine structures correlated with significantly
increased proliferation (Fig. 3 C). While activation of ErbB2
was shown to have similar effects on cell proliferation and
lumen formation, it had no such impact on the distribution
of cell adhesion molecules (Muthuswamy et al., 2001), sug-
gesting that this may represent a distinct capacity of auto-
crine CSF-1R signaling.
These effects could reflect a unique capability of autocrine
engagement of CSF-1R, such as activation of an internal
pool of newly synthesized molecules during trafficking to
the plasma membrane. Alternatively, the disruptive effects
of ligand coexpression could simply be a consequence of
chronic receptor stimulation. We addressed the latter possi-
bility by modifying the feeding schedule of 3D cultures,
which typically involves replenishment with fresh medium
every 4 d. When cultures were instead supplemented with
CSF-1 daily, structural disruption was perceptible by day 13
(Fig. 2 B). In contrast, daily treatment of parental MCF-
10As with EGF did not elicit a discohesive phenotype (Fig.
S2, available at http://www.jcb.org/cgi/content/full/jcb.
200309102/DC1). This suggests that while intracellular ac-
tivation of CSF-1R may occur in the autocrine context, it is
not necessary to produce the observed phenotype. Rather,
chronic exposure to ligand is sufficient to promote disrup-
tion of acinar architecture, whether provided exogenously or
in an autocrine fashion.
 
Autocrine CSF-1R activation alters the motility of 
MCF-10A monolayers
 
Perturbation of cadherin-mediated adhesion has been shown
to influence the movement of epithelial monolayers (Owens
et al., 2000). To determine whether CSF-1R activation al-
tered the motility of MCF-10A cells, we assessed the dynam-
ics of wound healing in response to exogenous or coex-
Figure 3. CSF-1 coexpression causes 
hyperproliferation and architectural 
disruption. MCF-10A cells expressing 
CSF-1R and vector control (CSF-1R/
Vector) or CSF-1 (CSF-1R/CSF-1) were 
cultured in Matrigel
TM in assay media 
with 10 ng/ml CSF-1 where noted (CSF-1). 
Confocal images of day 6 and day 17 
acinar cultures are shown. Structures were 
stained with DAPI (blue) along with Ki67 
(green) and E-cadherin (red) (A and C) or 
cleaved caspase-3 (green) and laminin 5 
(red) (B and D).
Figure 4. Autocrine CSF-1R activation 
alters wound healing dynamics in MCF-
10As. Confluent monolayers of MCF-10As 
expressing CSF-1R and vector control 
(CSF-1R/Vector) or CSF-1 (CSF-1R/CSF-1) 
were starved overnight in assay media. A 
wound was introduced into each mono-
layer with a pipette tip, and cells were 
incubated in assay media with 10 ng/ml 
CSF-1 where noted (CSF-1) for 48 h. 
Phase-contrast images of wound clo-
sure are representative of four separate 
experiments. 
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pressed CSF-1. Assays were performed in the presence of
mitomycin C to eliminate the contribution of proliferation
to wound closure. Receptor-expressing cells treated with 10
ng/ml CSF-1 began to migrate into the wound space as an
intact sheet from 
 
 
 
6–8 h after wounding, and required a
period of 
 
 
 
48 h to completely seal the wound. In contrast,
cells coexpressing CSF-1 rapidly broke away from the
wound margin and migrated into the wound space as indi-
vidual cells within 4 h after wounding. Complete closure
was achieved in 
 
 
 
24 h (Fig. 4).
 
CSF-1R promotes cadherin internalization and 
dissociation from the actin cytoskeleton
 
We then examined whether the altered cell–cell adhesion
and increased motility mediated by autocrine CSF-1R acti-
vation involved modulation of junctional complexes. Assess-
ment of E-cadherin localization at the wound margin re-
vealed that while discrete lateral staining was maintained in
cells expressing CSF-1R alone, it accumulated in intracellu-
lar vesicles in cells coexpressing receptor and ligand (Fig. 5
A). Similarly punctate E-cadherin staining was detected in
discohesive acini viewed at high magnification (Fig. 5 B). Al-
though internalization of E-cadherin may promote its degra-
dation, we did not observe a reduction in total E-cadherin in
lysates from cells coexpressing CSF-1R and CSF-1 (Fig. 5
C), and no degradation products were detected (Fujita et al.,
2002). In addition, both cell types exhibited a similar recov-
ery of E-cadherin after trypsin treatment, suggesting that the
adhesive defect is not a consequence of a decline in cadherin
synthesis (Fig. 5 D). Rather the disappearance of E-cadherin
from the membrane may be due to an increased rate of en-
docytosis or a defect in the recycling of internalized mole-
cules (Le et al., 1999).
The finding that E-cadherin levels are not altered by auto-
crine CSF-1R activation raised the question as to which
stage in the formation and maturation of cell junctions is
affected. Adhesion is initiated by homophilic cadherin con-
tact, which then consecutively triggers catenin binding, cad-
herin clustering, and recruitment of the actin cytoskele-
ton. Cytoskeletal association corresponds with a progression
from relatively weak adhesion to the generation of strong ad-
hesive forces and initiation of cell–cell compaction (Adams
et al., 1998). This transition can be observed when epithelial
cells are allowed to cluster in suspension. Initially, cells form
loose chains in which the membranes of contacting cells re-
main distinct. After several hours, compaction occurs be-
tween adjacent cells such that individual cell borders are no
longer discernible. Compaction of MCF-10As expressing
wild-type CSF-1R was detected within 4 h in suspension in
the presence of CSF-1, and by 8 h, few loosely associated
clusters remained. In contrast, cells coexpressing CSF-1R
and CSF-1 formed weak associations in suspension, but dis-
played limited progression to the compaction stage (Fig. 6).
This suggests that these cells retain adequate transmembrane
cadherin to initiate adhesive contacts; however, surface levels
may nonetheless be insufficient to initiate clustering and
promote cytoskeletal linkage. This contrasts with the ef-
fect of Ca
 
2
 
 
 
 sequestration, which prevents productive ho-
Figure 5. Coexpression of CSF-1 with CSF-1R elicits 
relocalization of E-cadherin from the membrane to 
intracellular vesicles. (A) MCF-10As expressing CSF-1R 
and vector control (CSF-1R/Vector) or CSF-1 (CSF-1R/
CSF-1) were fixed for E-cadherin immunofluorescence 
8 h after wounding. (B) Confocal images of day 21 acini 
expressing wild-type or active CSF-1R, stained with 
DAPI (blue) and E-cadherin (green). (C) Total levels of 
E-cadherin from RIPA lysates of MCF-10As expressing 
CSF-1R and vector control (Vector) or CSF-1 (CSF-1). 
(D) MCF-10As expressing CSF-1R and vector control 
(lanes 1, 3, 5, and 7) or CSF-1 (lanes 2, 4, 6, and 8) 
were harvested by treatment with EDTA (1–2 and 5–6) 
or trypsin (3–4 and 7–8) and placed in suspension
for 6 h before lysis in RIPA buffer and E-cadherin
immunoblotting. 
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mophilic cadherin interaction; MCF-10As placed in suspen-
sion in the presence of EGTA remained as single cells
(unpublished data).
Since autocrine CSF-1R activation does not result in cad-
herin loss, we evaluated whether it could compromise cell
adhesion by modulating the composition of adherens junc-
tion complexes. Various members of the catenin family asso-
ciate directly or indirectly with E-cadherin, and impact its
adhesive capacity and association with the cytoskeleton
(Herrenknecht et al., 1991; McCrea et al., 1991; Reynolds
et al., 1994). However, autocrine cells did not exhibit
changes in total levels of 
 
 
 
-catenin, p120 catenin, or 
 
 
 
-cate-
nin (Fig. 7 A). Furthermore, when E-cadherin was immuno-
precipitated from these cells, the levels of associated catenins
were likewise unaltered (Fig. 7 B). This is consistent with
previous data showing that adherens junction plaques are in-
ternalized as intact complexes (Boterberg et al., 2000). Fol-
lowing complex formation, interaction of 
 
 
 
-catenin with the
actin cytoskeleton is required for stabilization of adhesion
and cellular compaction (Adams and Nelson, 1998). To de-
termine if the proportion of E-cadherin associated with the
cytoskeletal fraction was reduced in autocrine CSF-1R cells,
solubility in the presence of a nonionic detergent was as-
sessed. A significant decrease in E-cadherin in Triton-insolu-
ble lysate fractions was observed in cells coexpressing CSF-1
(Fig. 7 C). This suggests that chronic CSF-1R signaling is
capable of thwarting the progression from initial cell contact
to strong adhesion, and provides a potential explanation for
its ability to disrupt 3D architecture.
 
Src kinases are required for CSF-1R disruption of
cell–cell adhesion
 
Stimulation of CSF-1R leads to the activation of multiple
signaling effectors, including PI3K and Src, which have been
implicated in the regulation of adhesion (Warren and Nel-
son, 1987; Roussel, 1998; Conacci-Sorrell et al., 2002). To
address which CSF-1R signaling pathways were responsible
for the observed architectural disruption, we generated mu-
tant variants of the constitutively active CSF-1R that en-
coded single tyrosine-to-phenylalanine substitutions at vari-
ous autophosphorylation sites on the receptor (Y561, Y699,
Y708, Y723, and Y923). MCF-10As infected with each mu-
tant receptor were examined in 3D culture for their ability
to recapitulate the discohesive phenotype. While the major-
ity of these substitutions were insufficient to prevent pertur-
bation of adhesion, mutation of Y561 significantly attenu-
ated junctional disruption without impeding proliferation
(Fig. 8 A). Mutation of the corresponding residue in the
murine receptor substantially reduced binding and activa-
tion of Src upon receptor activation, and phosphopeptides
spanning this region of the human receptor were shown to
bind Src in vitro (Alonso et al., 1995; Marks et al., 1999). In
agreement with these findings, we observed a decreased asso-
ciation of Src with the Y561F mutant receptor (Fig. 8 B). In
addition, using an antibody specific for the activation loop
phosphorylation site (Y419 in human Src), we observed that
at least two Src family kinases are activated by CSF-1R: Src
(M
 
r
 
60K) and Lyn (M
 
r
 
53 and 56K). Phosphorylation of both
proteins was reduced to basal levels in cells expressing the
Y561F mutant receptor (Fig. 8 C), while autophosphoryla-
tion of CSF-1R was unaffected (not depicted). This sug-
gested that the ability of constitutive CSF-1R signaling to
perturb cell–cell adhesion might be dependent on Src fam-
ily kinases.
To determine whether Src catalytic activity is necessary for
this perturbation, 3D cultures of cells expressing active CSF-
1R were treated from day 6 with SU6656, which selectively
inhibits Src at concentrations under 5 
 
 
 
M and does not im-
pact CSF-1R kinase activity (Blake et al., 2000). While
structures treated with vehicle exhibited a progressive dis-
ruption of cell adhesion, periodic treatment with the Src in-
hibitor preserved acinar integrity (Fig. 8 A). Furthermore,
overexpression of a kinase inactive, dominant-interfering
variant of Src (K295R) in MCF-10As coexpressing CSF-1R
Figure 6. Autocrine CSF-1R activation prevents adhesive compac-
tion. MCF-10As expressing CSF-1R and vector control (CSF-1R/
Vector) or CSF-1 (CSF-1R/CSF-1) were placed in suspension in assay 
media with 10 ng/ml CSF-1 where noted (CSF-1) for 6 h before 
harvest. Cells were resuspended in 0.5% agarose and spotted onto 
glass slides for DIC imaging.
Figure 7. Assembly of the cadherin–catenin complex is unaltered 
in CSF-1 coexpressing cells, but association with the cytoskeleton 
is disrupted. Parental MCF-10As and cells expressing CSF-1R and 
vector control (CSF-1R/Vector) or CSF-1 (CSF-1R/CSF-1) were grown 
to confluence in assay media before lysis. Media was supplemented 
with 5 ng/ml EGF for parental cells and 10 ng/ml CSF-1 for CSF-1R/
Vector cells. (A) RIPA lysates were probed for total levels of E-cad-
herin and catenin proteins. (B) E-cadherin immunoprecipitates from 
Triton lysates were probed for associated catenins. (C) Levels of 
E-cadherin in the Triton-soluble (TS) and Triton-insoluble (TI) lysate 
fractions were assayed. Actin is shown as a control for equal protein 
loading. 
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and CSF-1 also prevented junctional disruption in acinar
cultures (Fig. 8 D). Finally, levels of E-cadherin in the Tri-
ton-insoluble fraction were restored in Y561F cells (Fig. 8
E). Collectively, these data suggest that Src activity is essen-
tial for the destabilization of cell adhesion induced by
chronic CSF-1R signaling.
 
Constitutive c-Met stimulation does not persistently 
disrupt adhesion despite comparable levels of
Src activation
 
Several RTKs have been implicated in regulation of adhesive
contacts through mechanisms that involve Src activity (Co-
nacci-Sorrell et al., 2002). Activation of c-Met, which can al-
ter the composition of adherens junction complexes, induces
the extension of hollow tubules from MDCK cysts (Pollack
et al., 1998). To determine whether the discohesive pheno-
type elicited by constitutive CSF-1R activation in MCF-10A
acini was a consequence of chronic activation of other
RTKs, we assessed the morphology of acinar structures
formed by MCF-10As overexpressing c-Met alone or in con-
junction with HGF. When cells expressing c-Met were
grown in 3D culture in the presence of exogenous HGF (40
ng/ml), a small proportion of structures developed multiple
branching tubules (Fig. 9 A). Both the frequency and extent
of tubule formation were increased by HGF coexpression;
however, no additional alterations in acinar architecture
were observed. Notably, despite chronic activation of c-Met,
membrane localization of E-cadherin remained intact (Fig. 9
B). Thus the discohesive phenotype elicited by CSF-1R acti-
vation is a relatively distinct feature of this receptor. To de-
termine whether this distinction correlated with differing ca-
pacities of c-Met and CSF-1R to activate Src family kinases,
we assessed the level of Src activation in response to acute or
autocrine activation of each receptor. Acute stimulation of
c-Met or CSF-1R resulted in equivalent levels of Src phos-
phorylation; upon chronic stimulation of either receptor,
levels of Src activation were again comparable (Fig. 9 C).
 
Discussion
 
Despite significant evidence supporting a role for CSF-1R in
epithelial tumorigenesis, little is known about the mecha-
nisms by which autocrine CSF-1 activation may contribute
to tumor progression. We have used the MCF-10A mam-
mary epithelial cell line to assess the effects of ligand and re-
ceptor coexpression on epithelial motility and morphogene-
sis. We have found that constitutive CSF-1R signaling
causes uncontrolled proliferation, allowing these cells to
subvert growth-suppressive mechanisms typically opera-
tive in monolayer and 3D cultures. Furthermore, we ob-
served a profound perturbation of cell–cell adhesion, result-
ing in a striking disintegration of 3D acinar structures
and likely contributing to enhanced motility in MCF-10A
monolayers.
Using immunolocalization and fractionation studies, we
have demonstrated that autocrine CSF-1R signaling can
dramatically disrupt adherens junction–mediated adhesion.
The formation of adherens junctions, directed by ho-
mophilic interactions between the extracellular domains of
E-cadherin molecules on neighboring cells, is essential for
Figure 8. The ability of CSF-1R to promote junctional 
disruption is Src dependent. (A) MCF-10A cells 
expressing active CSF-1R (right and center), or active 
CSF-1R including a point mutation at the Src binding 
site (Y561F, left), were cultured in Matrigel
TM. Cultures 
were treated every 48 h with Src inhibitor SU6656 
(2  m) where noted. Brightfield images of day 15 acini 
are shown. (B) CSF-1R immunoprecipitates from MCF-
10As expressing active CSF-1R or active CSF-1R with 
the Y561F mutation were probed for Src association 
with the receptor. (C) MCF-10As expressing CSF-1R 
and vector control (CSF-1R/Vector) or CSF-1 (CSF-1R/
CSF-1), active CSF-1R, or active CSF-1R with the Y561F 
mutation were starved overnight in assay media. Cells 
were treated with 10 ng/ml CSF-1 before lysis where 
noted. Lysates were probed for Src tyrosine 419 
phosphorylation and total Src levels. (D) MCF-10As 
coexpressing CSF-1R and CSF-1 along with vector 
control or DN-Src (K295R) were cultured in Matrigel
TM. 
Phase-contrast images of day 16 acini are shown. (E) 
Levels of E-cadherin in the Triton-soluble (TS) and 
Triton-insoluble (TI) lysate fractions of MCF-10As 
expressing active CSF-1R or active CSF-1R with the 
Y561F mutation were assayed. Actin is shown as a 
control for equal protein loading. 
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epithelial cell–cell adhesion; other adhesive interactions are
limited in their absence. The cytoplasmic tail of E-cadherin
interacts with 
 
 
 
-catenin, which strengthens adhesive con-
tacts by tethering E-cadherin to the actin cytoskeleton via
interaction with 
 
 
 
-catenin (Herrenknecht et al., 1991; Mc-
Crea et al., 1991). Loss of cadherin function has been associ-
ated with migratory behavior in vitro, and is a common hall-
mark of invasive carcinoma in vivo (Kowalski et al., 2003).
While cellular remodeling involved in the formation of glan-
dular structures requires transient disruption of adhesive
contacts, the preservation of tissue architecture relies on sta-
ble intercellular interaction. Tubule formation in response
to the activation of c-Met in MDCK cysts involves local re-
distribution of cadherin complexes without dissolution of
cell–cell contacts (Pollack et al., 1998). In contrast to this
discrete morphogenetic response to an appropriate growth
factor signal, we have found that autocrine CSF-1R activa-
tion can dramatically and persistently disrupt cell–cell adhe-
sion in mammary epithelial structures in vitro. The resulting
disintegration of acinar integrity culminates in the release of
individual cells into the surrounding matrix.
Cell–cell adhesion functions not only to maintain the
physical integrity of the epithelial cell layer as a barrier be-
tween glandular and stromal compartments, but also con-
tributes to the maintenance of cell polarity and suppression
of proliferation (Watabe et al., 1994). Loss of membrane
E-cadherin in MCF-10A acini consistently correlated with
increased Ki67 staining, suggesting that compromised cell
adhesion may influence the uncontrolled proliferation ob-
served. Furthermore, perturbations of cell–cell contact have
been shown to promote migratory behavior, and appear to
play a role in tumor progression (Nollet et al., 1999). In
agreement with this, autocrine CSF-1R also accelerated
MCF-10A wound closure, not only increasing the rate of
cell motility, but also disrupting the sheet-like character of
epithelial cell movement. Enhanced motility likewise corre-
lated with reduced membrane E-cadherin staining. Despite
the capacity of CSF-1 to promote migration in this context,
it was unable to elicit invasive behavior through intact base-
ment membrane, as individual cells did not actively disperse
from disrupted acini. This suggests that cooperation with
additional factors may be required for CSF-1R activation to
promote invasion within the tumor microenvironment.
The disruption of adhesion resulting from autocrine CSF-
1R activation correlates with the translocation of E-cadherin
to intracellular vesicles and loss of Triton insolubility rather
than a decrease in total E-cadherin. These findings are con-
sistent with the possibility that the adhesive defect results
from dissociation of junctional complexes from the actin cy-
toskeleton and their concomitant internalization. Recent
data suggests that multiple regulators of cytoskeletal dynam-
ics impinge upon the assembly and maturation of adherens
junctions, and this interface may play as important a role in
regulation of adhesion as modulation of the composition of
junctional complexes (Braga et al., 1997). Association of ad-
herens junction complexes with the cytoskeleton might fur-
ther act as an important determinant in controlling the rate
of cadherin endocytosis and recycling.
The effects of autocrine CSF-1R signaling on cell–cell ad-
hesion are exquisitely dependent upon the sustained activa-
tion of Src kinases. Interfering with Src activity by pharma-
cological inhibition or expression of a dominant-inhibitory
Figure 9. Autocrine stimulation of c-Met does not 
persistently disrupt acinar adhesion despite comparable 
activation of Src. (A) MCF-10A cells expressing c-Met 
and vector control (c-Met/Vector) or HGF (c-Met/HGF) 
were cultured in Matrigel
TM in assay media with 
40 ng/ml HGF where noted (HGF). Brightfield images 
of day 5 and day 17 acini are shown. (B) 3D cultures 
of MCF-10As expressing c-Met and HGF were stained 
with DAPI (blue) and E-cadherin (green). Confocal 
image of day 19 structure is shown. (C) MCF-10As 
expressing CSF-1R and vector control or CSF-1, or 
c-Met and vector control or HGF were starved over-
night in assay media. Cells were treated with 10 ng/ml 
CSF-1 or 40 ng/ml HGF before lysis where noted. 
Lysates were probed for Src tyrosine 419 phosphoryla-
tion and total Src levels. 
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Src mutant, or by mutation of the Src binding site on the re-
ceptor, resulted in a complete preservation of acinar integ-
rity. Furthermore, Src inhibition restored the ability of cells
in suspension to undergo adhesive compaction, as well as the
controlled, sheet-like migration of cells in a wounded mono-
layer (unpublished data). Src can phosphorylate 
 
 
 
-catenin in
vitro, and v-Src has been shown to destabilize the association
of 
 
 
 
-catenin with E-cadherin, an effect that correlated with
phosphorylation of both proteins (Behrens et al., 1993;
Roura et al., 1999). In addition, p120 catenin was initially
identified as a Src substrate and was shown to be phosphory-
lated after RTK activation (Reynolds et al., 1989; Downing
and Reynolds, 1991). However, v-Src retained the ability to
disrupt cadherin cytoskeletal association in cells expressing
an E-cadherin/
 
 
 
-catenin fusion protein, excluding 
 
 
 
-cate-
nin as the relevant target and suggesting that Src activity
may also influence adherens junction stability indirectly
(Takeda et al., 1995). Src-mediated junctional disruption in
MCF-10As is likely to occur via such an indirect mecha-
nism, as we were unable to detect catenin phosphorylation
unless cells were treated with phosphatase inhibitors before
lysis, and levels were not enhanced by CSF-1R activation
(unpublished data).
Candidate Src targets include proteins that are localized to
cell junctions and influence but do not directly participate in
the adherens junction complex, such as ZO-1 or ezrin (Pu-
juguet et al., 2003). Alternatively, Src could exert its effects
by targeting a regulator of cadherin endocytosis, which
would account for the punctate accumulation of E-cadherin
observed upon autocrine CSF-1R activation. PKC
 
 
 
 has
been shown to stabilize adhesion by limiting cadherin en-
docytosis, and the ability of Src to mediate its degrada-
tion could play a role (Blake et al., 1999; Le et al., 2002).
Moreover, the GTPase ARF6 has been shown to act down-
stream of v-Src to promote cadherin endocytosis, and CSF-1
stimulation of macrophages induces its translocation to the
plasma membrane (Zhang et al., 1999; Palacios et al., 2001).
The inability of c-Met to elicit a similar disruption of acinar
architecture, despite its capacity to induce comparable levels
of Src activity, suggests that additional factors are involved
in CSF-1R–mediated perturbation of adhesion. Accessory
pathways activated by the receptor may be required to col-
laborate with Src; alternatively, CSF-1R may be uniquely
poised to colocalize active Src and its relevant target(s).
Studies to address this distinction and the aforementioned
potential targets are currently underway.
Coexpression of CSF-1R and CSF-1 is most often de-
tected in invasive tumors, and elevated serum levels of CSF-1
correlate with metastatic progression and poor prognosis
(Kacinski et al., 1991; Price et al., 1993). The ability of
CSF-1R to disrupt cell–cell adhesion, coupled with its ca-
pacity to promote cell motility and proliferation, corrobo-
rates that constitutive receptor signaling can coordinately
promote multiple biological activities associated with tumor
progression and invasion. Furthermore, our findings, in
conjunction with those of Ide et al. (2002), suggest that in-
hibition of epithelial CSF-1R signaling may prove to be a
valuable strategy in the treatment of invasive tumors. This
may be of particular relevance to malignancies that exhibit a
discohesive phenotype. Although often attributable to loss
or silencing of the CDH1 locus, a loss of membrane E-cad-
herin in tumors has also been observed in the absence of a
genetic lesion, suggesting that in vivo perturbations of cell
adhesion may also involve posttranslational mechanisms
(Kowalski et al., 2003).
 
Materials and methods
 
Cell culture and reagents
 
MCF-10A cells were obtained from American Type Culture Collection and
cultured in DME/F12 (Invitrogen) supplemented with 5% donor horse se-
rum, 20 ng/ml EGF, 10 
 
 
 
g/ml insulin, 0.5 
 
 
 
g/ml hydrocortisone, 100 ng/ml
cholera toxin, 50 U/ml penicillin, and 50 mg/ml streptomycin. Growth fac-
tor–reduced Matrigel
 
TM
 
 (BD Biosciences) with protein concentrations be-
tween 9 and 11 mg/ml was used. Antibodies to CSF-1R and c-Met were
obtained from Santa Cruz Biotechnology, Inc.; laminin 5 from Chemicon;
E-cadherin, 
 
 
 
-catenin, 
 
 
 
-catenin, and p120ctn from BD Transduction
Labs; Ki-67 from Zymed Laboratories; phospho-Src(Y416) from New En-
gland Biolabs, Inc.; and cleaved caspase-3 and phospho-CSF-1R(Y723)
from Cell Signaling Technologies. Src Mo327 has been previously de-
scribed (Lipsich et al., 1983). Src inhibitor SU6656 (Sugen, Inc.) was used
at 2 
 
 
 
M.
 
Retroviral vectors
 
pBabe-puro CSF-1 was constructed using an EcoRI fragment of pSMX hu-
man CSF-1 4.0 (Roussel et al., 1987). pMSCV human CSF-1R and CSF-1R
L301S/Y969F were provided by O. Witte (University of California, Los An-
geles, CA). The Y561F mutant receptor was generated by QuickChange
(Stratagene) site-directed mutagenesis using the following primers: forward,
5
 
 
 
-gagggcaacagttTtactttcatcgaccc-3
 
 
 
; reverse, 5
 
 
 
-gggtcgatgaaagtaAaactgt-
tgccctc-3
 
 
 
. pBabe-puro c-Met was constructed from pSP64 c-Met (Iyer et
al., 1990). pBabe-puro HGF was obtained from the Harvard Institute of
Proteomics FLEX library. pLNCX DN-Src(K295R) has been previously de-
scribed (Mukhopadhyay et al., 1995). Ecotropic retroviruses were pro-
duced by transfection of the Phoenix
 
TM
 
 ECO packaging line (Swift et al.,
1999) with 15 
 
 
 
g of DNA using Lipofectamine 2000
 
TM
 
 (Invitrogen). Viral
supernatants were collected on day 4 after transfection and passed through
a 0.45-
 
 
 
m filter before storage at 
 
 
 
80
 
 
 
C.
 
Generation of MCF-10A cell lines
 
MCF-10A cells expressing the ecotropic receptor (derived by infection
with pWZLneo mEcoR retrovirus, obtained from G. Daley, Harvard Medi-
cal School, Boston, MA) were plated at 4 
 
 
 
 10
 
5
 
 cells per 10-cm dish and
infected with the above retroviruses. Stable populations were obtained by
selection with 2 
 
 
 
g/ml puromycin or 200 
 
 
 
g/ml G418 (Sigma-Aldrich).
CSF-1R, c-Met, and Src overexpression were confirmed by immunoblot-
ting. Conditioned media from cells expressing CSF-1 was assayed for
ligand activity using the Quantikine CSF-1 ELISA Kit (R&D Systems).
 
Immunoprecipitation and immunoblotting
 
Monolayers were washed once in PBS and lysed in 1 ml Triton lysis buffer
(0.5% Triton X-100, 25 mM Tris pH 7.5, 150 mM NaCl, 2 mM CaCl
 
2
 
) or
RIPA buffer (1% Triton X-100, 1% NaDOC, 0.1% SDS, 20 mM Tris, pH
7.5, 150 mM NaCl, 1 mM EDTA) supplemented with protease and phos-
phatase inhibitors (1 
 
 
 
g/ml leupeptin, 1 
 
 
 
g/ml aprotinin, 1 
 
 
 
g/ml pep-
statin, 10 
 
 
 
g/ml PMSF, 1 mM NaVO
 
4
 
, 1 mM NaF) for 15 or 30 min at 4
 
 
 
C,
respectively. Lysates were cleared 15 min at 13,000 rpm and supernatants
were collected. Triton-insoluble (TI) pellets were resuspended in 2
 
 
 
 SDS
sample buffer.
For immunoprecipitations, 500 
 
 
 
g total protein in 500 
 
 
 
l total volume
was incubated with 1 
 
 
 
g primary antibody for 1 h at 4
 
 
 
C with rocking. 40
 
 
 
l of a protein G Sepharose slurry (Amersham Biosciences) was added for
an additional 40 min. Immune complexes were washed four times in lysis
buffer before elution in 60 
 
 
 
l 2
 
 
 
 SDS sample buffer. Immunoprecipitates
or cell lysates were resolved by 8–10% SDS-PAGE and immunoblotted us-
ing standard techniques. For fractionation experiments, equivalent amounts
of supernatant (TS) protein were loaded along with a proportionate volume
of each TI sample.
 
Morphogenesis assay
 
The 3D culture of MCF-10A cells on basement membrane was performed
as previously described (Debnath et al., 2003). Assay media (DME/F12
supplemented with 2% donor horse serum, 10 
 
 
 
g/ml insulin, 0.5 
 
 
 
g/ml
hydrocortisone, 100 ng/ml cholera toxin, 50 U/ml penicillin, and 50 mg/ 
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ml streptomycin) containing 5 ng/ml EGF, 10 ng/ml CSF-1 (R&D Systems),
or 40 ng/ml HGF (Van Andel Institute) was replaced every 4 d unless oth-
erwise noted. Where noted, SU6656 (2 
 
 
 
M) was added every 48 h without
replacement of media.
 
Cell compaction assay
Monolayers were harvested by treatment with 0.05% trypsin or 5 mM
EDTA in PBS for 30 min. 3   10
5 cells were resuspended in 1.5 ml assay
media   10 ng/ml CSF-1 and incubated for up to 12 h in 35-mm dishes
precoated with polyHEMA (6 mg/ml in 95% ethanol). Cell aggregates were
harvested by centrifugation at 200 rpm and washed once in PBS before
suspension in molten 0.5% agarose. Aliquots of resuspended aggregates
were dropped onto 1-mm glass slides and allowed to solidify. DIC imaging
was performed on a Nikon TE300 equipped with a CCD camera; images
were acquired using MetaMorph Version 4.6r6.
Wound healing assay
MCF-10A cells were seeded on glass coverslips at 5   10
4 cells per well
and grown to confluence before overnight starvation in assay media. A sin-
gle wound was introduced in the monolayer using a micropipette tip, and
the media replaced with assay media   10 ng/ml CSF-1 containing 1  g/
ml mitomycin C (Sigma-Aldrich). Wound closure was monitored for 48 h.
Immunofluorescence analysis and image acquisition
Monolayers were fixed 8 h after wounding for 20 min in 2% formalin, per-
meabilized 5 min with 0.2% Triton at 4 C, and washed three times in PBS.
Coverslips were blocked for 30 min in PBS   10% goat serum and incu-
bated 45 min each in primary and secondary antibody diluted 1:100 in
block, followed by three PBS washes. Cells were stained with DAPI,
washed, and mounted on 1-mm glass slides with ProLong Antifade (Mo-
lecular Probes). Images were acquired on a Nikon TE300 using Meta-
Morph Version 4.6r6. Immunostaining of acinar structures was performed
as previously described (Debnath et al., 2002). Confocal analyses were
performed using either the Nikon E800 Bio-Rad Laboratories or Carl Zeiss
MicroImaging, Inc. LSM410 confocal microscopy systems. Composite im-
ages were generated using MetaMorph Version 4.6r6 software.
Online supplemental material
The online supplemental material (Figs. S1 and S2) is available at http://
www.jcb.org/cgi/content/full/jcb.200309102/DC1. Fig. S1 shows images
that illustrate the progressive nature of the architectural disruption of MCF-
10A acini expressing CSF-1 and CSF-1R. Fig. S2 shows images that illus-
trate that daily EGF treatment does not elicit the discohesive phenotype in-
duced by similar treatment with CSF-1.
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